Authors: Buee, L Bussiere, T Buee-Scherrer, V Delacourte, A Hof, PR

Citation: L. Buee et al., Tau protein isoforms, phosphorylation and role in neurodegenerative disorders, BRAIN RES R, 33(1), 2000, pp. 95-130

Authors: Cecchelli, R Fenart, L Buee-Scherrer, V Dehouck, B Descamps, L Duhem, C Torpier, G Dehouck, MP

Citation: R. Cecchelli et al., In vitro models of the blood-brain barrier and their use in drug development, BLOOD-BRAIN BARRIER AND DRUG DELIVERY TO THE CNS, 2000, pp. 65-75

Authors: Cecchelli, R Dehouck, B Descamps, L Fenart, L Buee-Scherrer, V Duhem, C Lundquist, S Rentfel, M Torpier, G Dehouck, MP

Citation: R. Cecchelli et al., In vitro model for evaluating drug transport across the blood-brain barrier, ADV DRUG DE, 36(2-3), 1999, pp. 165-178

Authors: Perez-Tur, J Buee, L Morris, HR Waring, SC Onstead, L Wavrant-De Vrieze, F Crook, R Buee-Scherrer, V Hof, PR Petersen, RC McGeer, PL Delacourte, A Hutton, M Siddique, T Ahlskog, JE Hardy, J Steele, JC

Citation: J. Perez-tur et al., Neurodegenerative diseases of Guam: Analysis of TAU, NEUROLOGY, 53(2), 1999, pp. 411-413

Authors: Hasegawa, M Cuenda, A Spillantini, MG Thomas, GM Buee-Scherrer, V Cohen, P Goedert, M

Citation: M. Hasegawa et al., Stress-activated protein kinase-3 interacts with the PDZ domain of alpha 1-syntrophin - A mechanism for specific substrate recognition, J BIOL CHEM, 274(18), 1999, pp. 12626-12631